Diallyl Disulfide and Helicobacter pylori

Author(s):
Sayed Alireza MirsaneSayed Alireza Mirsane1,*, Nasrin OraeiNasrin Oraei2
1Kashan University of Medical Sciences, Kashan, IR Iran
2Lecturer of Education Office, Isfahan, IR Iran

International Journal of Infection:Vol. 4, issue 3; e40939
Published online:Aug 28, 2016
Article type:Letter
Received:Jul 19, 2016
Accepted:Aug 05, 2016
How to Cite:Mirsane SA, Oraei N. Diallyl Disulfide and Helicobacter pylori. Int J Infect. 2017;4(3):e40939. doi: https://doi.org/10.5812/iji.40939

Dear Editor,
Helicobacter pylori (H. pylori) is a Gram-negative bacteria that colonize in the stomach of about half of the world population is one of the most common bacterial infections worldwide. Helicobacter pylori can activate the immune response of the host. Despite a vigorous humeral and cellular immune response, if untreated, this infection becomes chronic and persists all over life (1-3). Helicobacter pylori gastric infection is a major risk factor of gastric cardiac cancer and migraine exacerbation. Unfortunately, after long-term infection, H. pylori may develop gastric cancer in some patients (4-7). According to a hadith by Muhammad the prophet (may peace be upon him), garlic is a remedial foodstuff with biological properties. On the other hand, diallyl disulfide (DADS or 4, 5-dithia-1, 7-octadiene) is the main organosulfur derivative of garlic (8). And also, DADS is found in foods such as chive oil (9), Chinese leek oil (10), garlic oil (10) and Dracocephalum kotschyi (11, 12). Researchers demonstrated that DADS is a useful and effective material to improve and treat H. pylori infection (11, 13). A study by O'Gara et al. had similar results; they concluded that antimicrobial activities of the diallyl sulfides increased with the number of sulfur atoms. They also suggested that DADS acts against the gastric ulcer caused by H. pylori (14). Corzo-Martínez showed that DADS also acts against the gastric ulcer caused by H. pylori (15). Researches indicated that H. pylori infection can motivate cells to synthesize and secrete 5-hydroxytryptamine (HT); and following that stimulate the cell to secrete 5-HT and create central nervous system (CNS) disorder by the brain-gut axis, which can increase the period and intensity of migraine headaches. Relieving H. pylori infection has beneficial results for migraine betterment because these interventions can reduce the period and intensity of this disorder (7, 16). Therefore, DADS can be a vulnerary and remedial factor for H. pylori infection and migraine. Based on the present study, it can be concluded that DADS has helpful and good efficiency in the treatment and control of H. pylori infection. Thus it can be as an anti-migraine, anti-gastric cardiac cancer and anti-gastric cancer; it can also be stated that DADS is a therapeutic substance for the other complications result from H. pylori infection. Finally, it is recommended to conduct more studies to find the new benefits of DADS.

References

  • 1.
    Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2(1):28-37. [PubMed ID: 11902583]. https://doi.org/10.1038/nrc703.
  • 2.
    Romano M, Ricci V, Zarrilli R. Mechanisms of disease: Helicobacter pylori-related gastric carcinogenesis--implications for chemoprevention. Nat Clin Pract Gastroenterol Hepatol. 2006;3(11):622-32. [PubMed ID: 17068500]. https://doi.org/10.1038/ncpgasthep0634.
  • 3.
    Salama NR, Hartung ML, Muller A. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol. 2013;11(6):385-99. [PubMed ID: 23652324]. https://doi.org/10.1038/nrmicro3016.
  • 4.
    Goldblum JR, Richter JE, Vaezi M, Falk GW, Rice TW, Peek RM. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol. 2002;97(2):302-11. [PubMed ID: 11866266]. https://doi.org/10.1111/j.1572-0241.2002.05462.x.
  • 5.
    Kamangar F, Qiao YL, Blaser MJ, Sun XD, Katki H, Fan JH, et al. Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer. 2007;96(1):172-6. [PubMed ID: 17179990]. https://doi.org/10.1038/sj.bjc.6603517.
  • 6.
    Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst. 2006;98(20):1445-52. [PubMed ID: 17047193]. https://doi.org/10.1093/jnci/djj393.
  • 7.
    Mirsane SA, Shafagh S. Effects of Helicobacter pylori Infection and Western Diet on Migraine. Gene Cell Tissue. 2016:39212.
  • 8.
    Di CX, Han L, Zhang H, Xu S, Mao AH, Sun C, et al. Diallyl disulfide attenuated carbon ion irradiation-induced apoptosis in mouse testis through changing the ratio of Tap73/DeltaNp73 via mitochondrial pathway. Sci Rep. 2015;5:16020. [PubMed ID: 26526304]. https://doi.org/10.1038/srep16020.
  • 9.
    Rattanachaikunsopon P, Phumkhachorn P. Diallyl sulfide content and antimicrobial activity against food-borne pathogenic bacteria of chives (Allium schoenoprasum). Biosci Biotechnol Biochem. 2008;72(11):2987-91. [PubMed ID: 18997412]. https://doi.org/10.1271/bbb.80482.
  • 10.
    Tsao SM, Yin MC. In-vitro antimicrobial activity of four diallyl sulphides occurring naturally in garlic and Chinese leek oils. J Med Microbiol. 2001;50(7):646-9. [PubMed ID: 11444776]. https://doi.org/10.1099/0022-1317-50-7-646.
  • 11.
    Mirsane SA, Mirsane SM. The effects of hydroalcoholic extract of dracocephalum kotschyi on blood glucose and lipid profile in diabetic rats. J Fasa Univ Med Sci. 2016;6(1):129-30.
  • 12.
    Eskandari M, Mohammadi J, Delaviz H, Hossieni E. The effects of hydroalcoholic extract of dracocephalum kotschyi on blood glucose and lipid profile in diabetic rats. J Fasa Univ Med Sci. 2016;5(4):526-33.
  • 13.
    Avato P, Tursi F, Vitali C, Miccolis V, Candido V. Allylsulfide constituents of garlic volatile oil as antimicrobial agents. Phytomedicine. Int J Phytotherapy Phytopharmacol. 2000;7(3):239-43.
  • 14.
    O'Gara EA, Hill DJ, Maslin DJ. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl Environ Microbiol. 2000;66(5):2269-73. [PubMed ID: 10788416].
  • 15.
    Corzo-Martínez M, Corzo N, Villamiel M. Biological properties of onions and garlic. Trends Food Sci Technol. 2007;18(12):609-25.
  • 16.
    Seyyedmajidi M, Banikarim SA, Ardalan A, Hozhabrossadati SH, Vafaeimanesh Norouzi A. Helicobacter pylori and Migraine: Is Eradication of Helicobacter pylori Effective in Relief of Migraine Headache? J. Caspian J Neurol Sci. 2016;2(4):29-35.

Similar Articles

10
Jun
2013

Comparison the Sensitivity of Stomach Mucus Touching Cytology and Urease Rapid Test in Helicobacter Pylori Diagnosis in Endoscopies Patients with Gastritis or Peptic Ulcer

Mohammad Jafari,
Alireza Khalilian,
Farshad Rostampour

Jafari M, Khalilian A, Rostampour F. Comparison the Sensitivity of Stomach Mucus Touching Cytology and Urease Rapid Test in Helicobacter Pylori Diagnosis in Endoscopies Patients with Gastritis or Peptic Ulcer. Jundishapur J Microbiol. 2013;6(4):e7446. doi: https://doi.org/10.5812/jjm.7446

31
Mar
1999

The role of Omeprazole and Amoxicillin combination in the eradication of Helicobacter Pylori

H Sheikholeslami

Sheikholeslami H. The role of Omeprazole and Amoxicillin combination in the eradication of Helicobacter Pylori. J Inflamm Dis. 1999;2(4):e154636. doi:

20
Jun
2012

Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in hemodialysis Patients

Mojgan Jalalzadeh,
Morteza Nazarian,
Jamshid Vafaeimanesh,
Fatemeh Mirzamohammadi

Jalalzadeh M, Nazarian M, Vafaeimanesh J, Mirzamohammadi F. Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in hemodialysis Patients. Nephro-Urol Mon. 2012;4(3):571-577. doi: https://doi.org/10.5812/numonthly.2794

27
Jan
2018
What’s New in Treatment of <i>Helicobacter pylori</i>?

What’s New in Treatment of Helicobacter pylori?

Masoud Mardani

Mardani M. What’s New in Treatment of Helicobacter pylori?. Arch Clin Infect Dis. 2018;13(1):e63955. doi: https://doi.org/10.5812/archcid.63955

10
Feb
2014

Helicobacter pylori and Serum Magnesium Level in Hemodialysis Patients

Hamid Nasri

Nasri H. Helicobacter pylori and Serum Magnesium Level in Hemodialysis Patients. Jundishapur J Microbiol. 2014;7(2):e11095. doi: https://doi.org/10.5812/jjm.11095


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles